Nrf2 pathway activation upon rotenone treatment in human iPSC-derived neural stem cells undergoing differentiation towards neurons and astrocytes
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 108, 457-471
Abstract
No abstract availableKeywords
Funding Information
- eu (266753)
This publication has 75 references indexed in Scilit:
- Human stem cell‐derived astrocytes and their application to studying Nrf2‐mediated neuroprotective pathways and therapeutics in neurodegenerationBritish Journal of Clinical Pharmacology, 2013
- Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cellsRedox Biology, 2013
- The promise of induced pluripotent stem cells in research and therapyNature, 2012
- The effects of oxidative stress on female reproduction: a reviewReproductive Biology and Endocrinology, 2012
- Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioningProceedings of the National Academy of Sciences, 2010
- Astrocyte-Specific Overexpression of Nrf2 Protects Striatal Neurons from Mitochondrial Complex II InhibitionToxicological Sciences, 2010
- Nrf2 promotes neuronal cell differentiationFree Radical Biology and Medicine, 2009
- Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cellsMolecular Neurodegeneration, 2008
- Keap1 Controls Postinduction Repression of the Nrf2-Mediated Antioxidant Response by Escorting Nuclear Export of Nrf2Molecular and Cellular Biology, 2007
- Expression of Nrf2 in Neurodegenerative DiseasesJournal of Neuropathology & Experimental Neurology, 2007